照明性亡:一种可见光激活的化物载体,用于化物运输和细胞死亡
Manzoor Ahmad1, Naveen J Roy1, Debashis Mondal1
1Department of Chemistry, Indian Institute of Science Education and Research Pune, Dr Homi Bhabha Road, Pashan, Pune 411008, Maharashtra, India. ptalukdar@iiserpune.ac.in.
研究人员开发了新的光激活化物载体用于癌症治疗. 这些由可见光激活的前载体表现出更好的选择性和减少对健康细胞的损伤,增强了癌症治疗潜力.
科学领域:
- 生物化学 生化学
- 材料科学 材料科学 材料科学
- 在瘤学瘤学.
背景情况:
- 合成化物载体诱导癌细胞亡,但缺乏选择性,损害健康细胞.
- 光激活系统提供时空控制,但通常需要有害的紫外线辐射.
- 现有的光响应系统在组织透和光毒性方面存在局限性.
研究的目的:
- 开发新的光响应性化物载体,提高癌症治疗的选择性.
- 为了将光响应系统的激活波长转移到可见光谱中.
- 为了研究英多尔-2-碳胺衍生物作为前载体的疗效.
主要方法:
- 合成3替代的英多尔-2-碳胺离子载体及其与-尼特罗 (ONB) 相关的原载体.
- 加入电子捐赠替代剂来调整ONB光分离组的吸收波长.
- 使用可见光在MCF-7癌细胞中合成的前载体的光激活研究.
主要成果:
- 合成的前载体在吸收波长中呈现红色转移,其中一个波长延伸到500纳米.
- 在400nm光线下,所有前体细胞都在MCF-7癌细胞中被成功光激活.
- 基于N,N-二甲基的前载体在450nm时显示光激活,这是一个更高,更生物相容的波长.
结论:
- 新型的英多尔-2-碳胺载体可以通过可见光激活,克服紫外线限制.
- 开发的系统显示了选择性癌症治疗的潜力,减少了光毒性.
- 这一进展对于生物系统中可光激活药物的实际应用至关重要.
更多相关视频
10:45Monitoring Cleaved Caspase-3 Activity and Apoptosis of Immortalized Oligodendroglial Cells using Live-cell Imaging and Cleaveable Fluorogenic-dye Substrates Following Potassium-induced Membrane Depola
Published on: January 13, 2012
08:39Single-Cell Optical Action Potential Measurement in Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes
Published on: December 22, 2020
相关概念视频
Channel Rhodopsins
Rhodopsins belong to the family of cell surface proteins called G-protein coupled receptors,...
G-Protein Gated Ion Channels
Sensory...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several...
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
The Intrinsic Apoptotic Pathway
The Extrinsic Apoptotic Pathway
